Key result
Monoclonal antibodies reactive with epitopes on the hemagglutinin-neuraminidase glycoprotein of mumps virus protected infected newborn hamsters from lethal central nervous system infection.
Why the study?
Does monoclonal antibody therapy protect against lethal mumps virus meningoencephalitis in newborn Syrian hamsters?
Does monoclonal antibody therapy protect against lethal mumps virus meningoencephalitis in newborn Syrian hamsters?
Monoclonal antibodies targeting the hemagglutinin-neuraminidase glycoprotein of mumps virus provide protection against lethal meningoencephalitis in a hamster model.
Answers are grounded in this paper and cite their sources.
Anti-HN mAb protection in hamster CNS infection is hypothesis-generating; leaves open translation to human neonatal meningoencephalitis.
Newborn Syrian hamsters were challanged with an intracerebral inoculum containing 128 50% lethal doses of the Kilham strain of mumps virus and treated 24 h later with a single intraperitoneal injection of mouse monoclonal antibody. Monoclonal antibodies reactive with epitopes on the fusion glycoprotein of mumps virus could not inhibit hemagglutination or neutralize infectivity in vitro and failed to provide biologically important protection against the in vivo infection. In contrast, monoclonal antibodies reactive with epitopes on the hemagglutinin-neuraminidase glycoprotein of mumps virus inhibited hemagglutination and neutralized infectivity in vitro and protected infected animals from the otherwise lethal central nervous system virus infection. Similar protection was provided by both purified immunoglobulin and F(ab')2 fragments. Immuno-cytochemical and virological studies showed diminished virus antigen and virus titers in the brains of successfully treated animals. It appears that a topographically restricted region of the hemagglutinin-neuraminidase molecule of the Kilham strain of mumps virus is of critical importance for immune recognition by the infected host.
No takes yet. Share an insight, caveat, or question.
Wolinsky et al. (1985) studied Experimental mumps virus meningoencephalitis. Monoclonal antibodies reactive with epitopes on the hemagglutinin-neuraminidase glycoprotein of mumps virus vs. Monoclonal antibodies reactive with epitopes on the fusion glycoprotein was evaluated on Protection against lethal central nervous system virus infection. Monoclonal antibodies reactive with epitopes on the hemagglutinin-neuraminidase glycoprotein of mumps virus protected infected newborn hamsters from lethal central nervous system infection.
Synapse has enriched 10 related papers. Consider them for comparative context: